- Home
- DOMO vs EYPT Comparison
DOMO vs EYPT Comparison
Compare DOMO & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMO
- EYPT
- Stock Information
- Founded
- DOMO 2010
- EYPT 1987
- Country
- DOMO United States
- EYPT United States
- Employees
- DOMO N/A
- EYPT N/A
- Industry
- DOMO Computer Software: Prepackaged Software
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- DOMO Technology
- EYPT Industrials
- Exchange
- DOMO Nasdaq
- EYPT Nasdaq
- Market Cap
- DOMO 436.2M
- EYPT 484.4M
- IPO Year
- DOMO 2018
- EYPT 2005
- Fundamental
- Price
- DOMO $12.70
- EYPT $8.42
- Analyst Decision
- DOMO Hold
- EYPT Strong Buy
- Analyst Count
- DOMO 6
- EYPT 8
- Target Price
- DOMO $10.67
- EYPT $24.75
- AVG Volume (30 Days)
- DOMO 1.1M
- EYPT 917.5K
- Earning Date
- DOMO 05-21-2025
- EYPT 08-06-2025
- Dividend Yield
- DOMO N/A
- EYPT N/A
- EPS Growth
- DOMO N/A
- EYPT N/A
- EPS
- DOMO N/A
- EYPT N/A
- Revenue
- DOMO $317,052,000.00
- EYPT $56,042,000.00
- Revenue This Year
- DOMO $1.71
- EYPT N/A
- Revenue Next Year
- DOMO $2.43
- EYPT N/A
- P/E Ratio
- DOMO N/A
- EYPT N/A
- Revenue Growth
- DOMO N/A
- EYPT 12.04
- 52 Week Low
- DOMO $6.01
- EYPT $3.91
- 52 Week High
- DOMO $14.83
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- DOMO 56.01
- EYPT 59.17
- Support Level
- DOMO $12.86
- EYPT $8.50
- Resistance Level
- DOMO $13.75
- EYPT $9.60
- Average True Range (ATR)
- DOMO 0.70
- EYPT 0.59
- MACD
- DOMO -0.28
- EYPT -0.01
- Stochastic Oscillator
- DOMO 7.39
- EYPT 52.61
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.